Le Ma Selected Research

bulleyaconitine A

1/2021	Bulleyaconitine A Inhibits Morphine-Induced Withdrawal Symptoms, Conditioned Place Preference, and Locomotor Sensitization Via Microglial Dynorphin A Expression.
1/2020	Bulleyaconitine A Exerts Antianxiety and Antivisceral Hypersensitivity Effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Le Ma Research Topics

Disease

13	Macular Degeneration (Age-Related Maculopathy) 01/2022 - 01/2010
11	Neoplasms (Cancer) 01/2022 - 01/2008
5	Infections 07/2022 - 04/2021
5	Atherosclerosis 06/2019 - 12/2011
5	Cataract (Cataracts) 01/2019 - 01/2010
4	Stroke (Strokes) 08/2022 - 06/2018
4	Wounds and Injuries (Trauma) 07/2022 - 03/2013
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2009
4	Neuralgia (Stump Neuralgia) 10/2021 - 01/2020
4	Hypersensitivity (Allergy) 10/2021 - 01/2020
4	Pain (Aches) 10/2021 - 01/2020
4	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2020 - 10/2015
3	Coronary Disease (Coronary Heart Disease) 01/2022 - 01/2018
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 03/2015
3	Breast Neoplasms (Breast Cancer) 12/2021 - 01/2017
3	Hyperalgesia 10/2021 - 01/2021
3	Inflammation (Inflammations) 03/2019 - 06/2009
3	AIDS-Related Complex (ARC) 01/2019 - 01/2014
2	Chronic Disease (Chronic Diseases) 01/2022 - 01/2009
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2021 - 01/2021
2	Hepatocellular Carcinoma (Hepatoma) 09/2021 - 10/2017
2	Multiple Myeloma 01/2021 - 08/2017
2	Obesity 01/2021 - 01/2017
2	Leukemia 01/2021 - 06/2013
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 01/2018
2	Carcinoma (Carcinomatosis) 01/2020 - 01/2020
2	Osteosarcoma (Osteogenic Sarcoma) 09/2018 - 06/2011
1	Prostatic Neoplasms (Prostate Cancer) 09/2022
1	Cognitive Dysfunction 08/2022
1	Malnutrition (Nutritional Deficiencies) 03/2022
1	Vomiting 01/2022
1	Hypotension (Low Blood Pressure) 01/2022
1	Drug Resistant Epilepsy 01/2022
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2022
1	Diarrhea 01/2022
1	Fish Diseases (Fish Disease) 01/2022
1	Nausea 01/2022
1	COVID-19 01/2022
1	Temporal Lobe Epilepsy 01/2022

Drug/Important Bio-Agent (IBA)

15	LuteinIBA 01/2019 - 01/2009
11	ZeaxanthinsIBA 01/2019 - 01/2010
7	Biomarkers (Surrogate Marker)IBA 08/2022 - 02/2013
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2009
5	Carotenoids (Carotene)IBA 03/2022 - 12/2011
4	VaccinesIBA 01/2022 - 12/2017
4	MicroRNAs (MicroRNA)IBA 01/2022 - 08/2017
4	Pharmaceutical PreparationsIBA 06/2021 - 06/2011
3	AntigensIBA 09/2022 - 01/2012
3	VitaminsIBA 03/2022 - 01/2019
3	Minocycline (Cyclops)FDA LinkGeneric 01/2021 - 01/2021
3	Dynorphins (Dynorphin)IBA 01/2021 - 01/2020
3	AutoantibodiesIBA 01/2020 - 09/2010
3	CytokinesIBA 10/2017 - 11/2012
3	LipidsIBA 10/2016 - 06/2009
3	Macular PigmentIBA 07/2016 - 11/2012
2	InterleukinsIBA 08/2022 - 10/2021
2	CollagenIBA 07/2022 - 03/2022
2	CelluloseIBA 07/2022 - 03/2022
2	IsoflavonesIBA 01/2022 - 01/2020
2	Long Noncoding RNAIBA 01/2022 - 09/2021
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2022 - 12/2021
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2021
2	Glucagon-Like Peptide-1 ReceptorIBA 10/2021 - 01/2021
2	Interleukin-10 (Interleukin 10)IBA 10/2021 - 01/2021
2	EndorphinsIBA 10/2021 - 01/2021
2	Exenatide (Byetta)FDA Link 10/2021 - 01/2021
2	RNA (Ribonucleic Acid)IBA 05/2021 - 08/2020
2	Therapeutic UsesIBA 01/2021 - 03/2013
2	bulleyaconitine AIBA 01/2021 - 01/2020
2	Analgesics (Analgesic Drugs)IBA 01/2021 - 01/2020
2	salicylhydroxamic acid (SHAM)IBA 01/2021 - 01/2021
2	CalciumIBA 01/2021 - 12/2017
2	AntibodiesIBA 01/2020 - 01/2012
2	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2020 - 11/2018
2	Intravenous Immunoglobulins (IVIG)FDA Link 03/2019 - 11/2018
2	GlucosinolatesIBA 01/2018 - 01/2018
2	C-Reactive ProteinIBA 01/2018 - 06/2009
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 03/2013
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 06/2011
1	Interleukin-17 (Interleukin 17)IBA 08/2022
1	Interferon-gamma (Interferon, gamma)IBA 08/2022
1	Sulfates (Sulfates, Inorganic)IBA 03/2022
1	CopperIBA 03/2022
1	polydopamineIBA 03/2022
1	Eicosapentaenoic AcidIBA 01/2022
1	Inactivated VaccinesIBA 01/2022
1	propionic acid (potassium propionate)IBA 01/2022
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022
1	antineoplaston A10 (A 10)IBA 01/2022
1	Docosahexaenoic AcidsIBA 01/2022
1	docosapentaenoic acidIBA 01/2022
1	alpha-Linolenic Acid (Linolenic Acid)IBA 01/2022
1	AMPA Receptors (AMPA Receptor)IBA 01/2022
1	Radiation-Protective Agents (Radiation Protectants)IBA 01/2022
1	perampanelIBA 01/2022

Therapy/Procedure

5	Therapeutics 06/2021 - 03/2013
3	Spinal Injections 10/2021 - 01/2021
2	Ligation 10/2021 - 01/2021
2	Hyperbaric Oxygenation 06/2013 - 03/2013
1	Radiotherapy 01/2022